Loading...
An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection
Previously reported prognostic signatures for predicting the prognoses of postsurgical hepatocellular carcinoma (HCC) patients are commonly based on predefined risk scores, which are hardly applicable to samples measured by different laboratories. To solve this problem, using gene expression profile...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5029687/ https://ncbi.nlm.nih.gov/pubmed/27006471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8212 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|